No segmentation disclosed for this filer. n/a
PD-Rx Pharmaceuticals, Inc. booked $18.3M in FY2024 revenue, contracting 3.2% year over year — slower than 64% of Healthcare companies we track, at a -1.4% net margin.
No filings loaded — no CIK (non-SEC filer).